Home > Name List By i > Insulin-likegrowth factor I

CAS No 67763-96-6 , Insulin-likegrowth factor I

  • Name: Insulin-likegrowth factor I
  • Synonyms: Insulin-likegrowth factor I; Somatomedin 1; Sulfationfactor C;IGF-I; Insulin-like growth factor 1;IGF-1; Somatomedin C;
  • CAS Registry Number:
  • Molecular Weight: 0
  • InChI: InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1
  • Molecular Formula: C3H7NO3
  • Molecular Structure:CAS No:67763-96-6 Insulin-likegrowth factor I

Related products

Search by region :

Select to

67763-96-6 Insulin-likegrowth factor I

  • United States PEPTIDELAB null
  • Tel: 707 745 1500
  • Address: Primary SIC: Leather Goods, Not Elsewhere Classified, Primary NAICS: All Other Leather Good Manufacturing null,nullUnited States
Contact Supplier

67763-96-6 Insulin-likegrowth factor I

  • United States Scripps Laboratories null
  • Tel: +1-858-546-5800
  • Fax: +1-858-546-5812
  • Address: 6838 Flanders Drive San Diego, CA 92121-2904 USA null,nullUnited States
Contact Supplier

67763-96-6 Insulin-likegrowth factor I

  • United States PEPROTECH [Manufacturers]
  • Tel: 800 436 9910
  • Fax: (609) 497-0321
  • Address: P.O. Box 275 Rocky Hill, NJ 08553 Rocky Hill,Rocky HillUnited States
Contact Supplier

67763-96-6 Insulin-likegrowth factor I

  • China BIOSOURCE [Importer/Exporter]
  • Tel: (86-10) 5808-5888
  • Fax: (86-10) 6780-6535
  • Address: No.7, Rong Chang East Street Long Sheng Industry Park, Building 203 BDA Beijing, 100176 Beijing,BeijingChina
Contact Supplier

67763-96-6 INSULIN-LIKE GROWTH FACTOR-I (IGF-I), HUMAN RECOMBINANT

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of Insulin-likegrowth factor I
Title: Insulin-like Growth Factors
Synonyms: IGFs
Literature References: Family of conserved peptide hormones structurally homologous with insulin. Two major circulating forms mediate the growth promoting effects of somatotropin, q.v. IGF-I regulates both prenatal and postnatal growth; IGF-II is a key factor in fetal development. IGFs are produced primarily in the liver under the regulation of growth hormone; also produced locally by most tissues. Transported in the serum by IGF binding proteins (or IGFBP) that prolong the half-life and regulate the metabolic effects of IGFs. Discovered and termed sulphation factors because of their ability to stimulate the incorporation of sulfate by cartilage: W. D. Salmon, W. H. Daughaday, J. Lab. Clin. Med. 49, 825 (1957). These peptides have also been referred to as NSILA-S, or non-suppressible insulin-like acting substance. The designation somatomedin was proposed to connote the intermediary relationship to somatotropin: W. H. Daughaday et al., Nature 235, 107 (1972). Discussion of nomenclature: idem et al., J. Clin. Endocrinol. Metab. 65, 1075 (1987). Isoln, chemical characterization, biological properties of IGF-I and IGF-II: E. Rinderknecht, R. E. Humbel, Proc. Natl. Acad. Sci. USA 73, 2365, 4379 (1976). Amino acid sequence of IGF-I: eidem, J. Biol. Chem. 253, 2769 (1978); of IGF-II: eidem, FEBS Lett. 89, 283 (1978). Total synthesis of human IGF-I: C. H. Li et al., Proc. Natl. Acad. Sci. USA 80, 2216 (1983); of human IGF-II: eidem, Biochem. Biophys. Res. Commun. 127, 420 (1985). Review of molecular biology: W. H. Daughaday, P. Rotwein, Endocr. Rev. 10, 68-91 (1989); of mechanism of action: A. Spagnoli, R. C. Rosenfeld, Endocrinol. Metab. Clin. North Am. 25, 615-631 (1996). Review of IGF binding proteins: D. R. Clemmons, Cytokine Growth Factor Rev. 8, 45-62 (1997). Reviews: C. E. H. Stewart, P. Rotwein, Physiol. Rev. 76, 1005-1026 (1996); D. Le Roith, N. Engl. J. Med. 336, 633-640 (1997).
 
Derivative Type: Insulin-like Growth Factor I
CAS Registry Number: 67763-96-6
Synonyms: IGF-I; somatomedin 1; somatomedin C; SM-C
Literature References: Single chain, basic protein containing 70 amino acid residues. Review of physiology and potential therapeutic uses: E. R. Froesch et al., Diabetes Metab. Rev. 12, 195-215 (1996).
 
Derivative Type: Insulin-like Growth Factor II
CAS Registry Number: 67763-97-7
Synonyms: IGF-II; multiplication-stimulating activity III-2; MSA III-2
Properties: Single chain, slightly acidic protein containing 66 or 67 amino acid residues depending on the species.
 
Derivative Type: Mecasermin
CAS Registry Number: 68562-41-4
Synonyms: Human insulin-like growth factor I
Molecular Formula: C331H512N94O101S7
Molecular Weight: 7648.63
Percent Composition: C 51.98%, H 6.75%, N 17.21%, O 21.13%, S 2.93%
Literature References: Myotrophin (Cephalon) and Somason (Fujisawa) are recombinant products. Clinical trial in amyotrophic lateral sclerosis: D. J. Lange et al., Neurology 47, Suppl. 2, S93 (1996).
 
Therap-Cat: In treatment of growth hormone insensitivity syndrome and insulin resistance.